期刊文献+

一种单核细胞渗出模型的建立及其在内皮细胞通透性检测中的应用 被引量:1

Establishment of one kind of monocyte diapedesis model and its application in assessment of endothelial cells permeability
下载PDF
导出
摘要 目的建立一种单核细胞渗出模型并探讨其作为内皮细胞通透性检测模型的可行性。方法将培养的人脐静脉内皮细胞与浓度为100μg/ml晚期糖基化终产物修饰的人血清白蛋白分别共同培养2、4、6、8、12h,同样浓度的人血清白蛋白加入人脐静脉内皮细胞作为对照组,然后采用Transewell模型,利用5一氯甲基二乙酸荧光素标记的人白血病单核细胞渗出数量反映内皮细胞的通透性。结果与对照组相比,晚期糖基化终产物修饰的人血清白蛋白以时间依赖的方式增加白血病单核细胞渗出的数量,且在刺激8h组白血病单核细胞渗出的数量达高峰(P〈0.05)。结论用5一氯甲基二乙酸荧光素标记的白血病单核细胞建立的单核细胞渗出模型为体外研究内皮细胞通透性提供了一种简便、可行的方法。 Objective To establish one kind of monocyte diapedesis model and study its application in the assessment of endothelial cells permeability. Methods Human umbilical vein endothelial eells(HUVECs) were cultured in vitro with AGEs-modified human serum albumin(AGEs-HSA) in the concentration of 100 μg/ml for 2,4,6,8 and 12 hours respectively. In control group, HSA of the same concentration was administered to HUVECs cells. By using transewell model, the permeability of endothelial cells was presented by the amount of permeated 5-chloromethylfluorescein diacetate(CMF- DA)-labeled human acute monocytic leukemia cell line(THP-1) cells. Results Compared to controls, AGEs-HSA increased the amount of THP-1 cells in a time-dependent manner, and the amount of permeated THP-I cells reached the peak at 8 hours in stimulating group(P〈0. 05). Conclusions The monocyte diapedesis model based on CMFDA-labeled human THP-1 monocytes provides a simple and reliable means for studying the permeability of endothelial cells in vitro.
出处 《临床肾脏病杂志》 2011年第6期279-282,共4页 Journal Of Clinical Nephrology
基金 基金项目:国家自然科学基金(30600289)
关键词 内皮细胞 单核细胞 白血病 Endothelial Cells Monoeytes Leukemia
  • 相关文献

参考文献9

  • 1Guo ZJ, Niu HX, Hou FF, et al. Advanced oxidation protein prod- ucts activate vascular endothelial cells via a RAGE-mediated sig- naling pathway. Antioxid Redox Signal,2008,10: I699-1712.
  • 2Kayyali US, Pennella CM, Trujillo C, et al. Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK- activated protein kinase MK2. J Biol Chem, 2002, 277: 42596- 42602.
  • 3Georgios E, Konstantinos T, Dimitri PM, et al. Atherogenesis in renal patients~A model of vascular disease? Curr Vasc Pharma- col,2008,6:93-107.
  • 4Birukova AA, Adyshev D. GEF-H1 is involved in agonist-indueed human pulmonary endothelial harrier dysfunction. Am J PhysiolLung Cell Mol Physiol, 2006,290 : 540-548.
  • 5陈朝红,刘志红,余晨,吴义超.一种体外研究肾小球内皮细胞通透性的方法[J].肾脏病与透析肾移植杂志,2002,11(5):497-500. 被引量:6
  • 6Dimitrijevic OB, Stamatovic SM, Keep RF, et al. Effects of the chemokine CCL2 on blood-brain barrier permeability during is- chemia-reperfusion injury. J Cereb Blood Flow Metab, 2006, 26.- 797-810.
  • 7Guo XH, Huang QB,Chen B, et al. Advanced glycation end prod- ucts induce aetin rearrangement and subsequent hyperpermeabili- ty of endothelial cells. APMIS, 2006,114: 874-883.
  • 8Genco RJ,Offenbacher S, Beck JD. Periodontal disease and cardi- ovascular disease epidemiology and possible mechanisms. J Am Dent Assoc, 2002,133 : 14-22.
  • 9Meurman J H, Sanz M, J anket SJ. Oral healt h, atherosclerosis, and cardiovascular disease, Crit Rev Oral Biol Med, 2004, :5: 403- 413.

二级参考文献2

共引文献5

同被引文献18

  • 1Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey [ J ]. Lancet, 2012, 379(9818) :815-822.
  • 2Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during athero- genesis [ J ]. Science, 1991,251 (4995) : 788-791.
  • 3Harrison D, Griendling KK, Landmesser U, et al. Role of oxidative stress in atherosclerosis [ J ]. Am J Cardiol, 2003, 91(3A) :7A-11A.
  • 4Guo Z J, Niu HX, Hou FF, et al. Advanced oxidation pro- tein products activate vascular endothelial ceils via a RAGE-mediated signaling pathway [ J ]. Antioxid Redox Signal, 2008, 10(10) : 1699-1712.
  • 5Witko-Sarsat V, Gausson V, Nguyen AT, et al. AOPP- HSA-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcys- teine treatment in dialysis patients [ J ]. Kidney Int, 2003, 64( 1 ) :82-91.
  • 6Wei Y, Sowers JR, Nistala R, et al. Angiotensin II-in- duced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells [ J ]. J Biol Chem, 2006, 281 (46) : 35137-35146.
  • 7Witko-Sarsat V, Friedlander M, Nguyen Khoa T, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal fai- lure[J]. J Immunol, 1998, 161(5):2524-2532.
  • 8Kalousova M, Skrha J, Zima T. Advanced glycation end- products and advanced oxidation protein products in pa- tients with diabetes mellitus [ J ]. Physiol Res, 2002, 51 (6) : 597-604.
  • 9Ozenirler S, Erkan G, Gulbahar O, et al. Serum levels of advanced oxidation protein products, malonyldialdehyde, and total radical trapping antioxidant parameter in patients with chronic hepatitis C [ J ]. Turk J Gastroenterol, 2011, 22(1): 47-53.
  • 10Li H, Horke S, Forstermann U. Vascular oxidative stress, nitric oxide and atherosclerosis [ J ]. Atherosclerosis, 2014, 237(1) :208-219.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部